Semiconductor Chip and Time Domain Sequencing™ Technology Will Advance Drug Discovery and Diagnostics, Enabling People to Live Healthier and Longer Lives Key Takeaways: Next-generation single-molecule protein sequencing technology is poised to transform the science and research community’s understanding of the proteome by unlocking unprecedented insights about the human body — just as the advent of […]

 Veteran Life Sciences Executive to Oversee Commercial Launch of Next-Generation Single-Molecule Protein Sequencing Platform GUILFORD, Conn.–(BUSINESS WIRE)–Oct. 4, 2022– Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next-generation single-molecule protein sequencing platform, today announced the appointment of Jeff Hawkins as Chief Executive Officer. Mr. Hawkins will succeed […]

GUILFORD, Conn.–(BUSINESS WIRE)–Aug. 26, 2022 — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first-next generation single-molecule protein sequencing platform, today announced that it will be participating in the Morgan Stanley 20th Annual Global Healthcare Conference taking place at the Sheraton New York, NY, on September 12-14, 2022. […]

GUILFORD, Conn.–(BUSINESS WIRE)– Aug. 08, 2022 — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next-generation, single-molecule protein sequencing platform, today announced financial results for the second quarter ending June 30, 2022. Recent Business Highlights Successfully demonstrated the recognition of 15 out of 20 amino acids, representing a […]

GUILFORD, Conn.–(BUSINESS WIRE)– Jul. 18, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing the first next generation single molecule protein sequencing, today announced that it will report financial results for the second quarter 2022 after market close on Monday, August 8, 2022. Company management will host a conference call […]

First of its kind life sciences company continues focus on commercial launch of next-generation protein sequencing platform GUILFORD, Conn.–(BUSINESS WIRE)– June 22, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, is set to join the broad-market Russell 2000® Index at the conclusion of the 2022 Russell indexes […]

GUILFORD, Conn.–(BUSINESS WIRE)– June 16, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced the appointment of Vikram Bajaj, Ph.D., co-founder and former Chief Scientific Officer of Verily (formerly Google Life Sciences), to its Board of Directors. Dr. Bajaj is a managing director at Foresite Capital, […]

Quantum-Si demonstrates a path to enable >70% coverage of the human proteome and the identification of up to 90% of proteins, including post-translational modifications Company continues to advance the core technology as it progresses towards commercialization of its Platinum™ Protein Sequencing Platform later this year GUILFORD, Conn.–(BUSINESS WIRE)– Jun. 1, 2022 — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” […]

GUILFORD, Conn.–(BUSINESS WIRE)– May 25, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the 2022 Jefferies Healthcare Conference taking place at the Marriott Marquis, New York, NY, on June 8-10, 2022. Quantum-Si’s management is scheduled to present on Friday, […]

GUILFORD, Conn.–(BUSINESS WIRE)– May 17, 2022–Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the Next-Generation Protein Analysis and Detection Conference, a VIB Tools & Technologies conference, taking place in Ghent, Belgium on May 30-31, 2022. Brian Reed, Ph.D., Head […]